Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1970 1
1972 1
1976 1
1977 1
1982 2
1986 2
1987 1
1989 2
1992 2
1993 1
1995 9
1996 8
1997 5
1998 8
1999 15
2000 12
2001 12
2002 9
2003 9
2004 8
2005 20
2006 10
2007 17
2008 16
2009 14
2010 6
2011 16
2012 10
2013 10
2014 13
2015 15
2016 15
2017 11
2018 11
2019 9
2020 13
2021 9
2022 5
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

306 results

Results by year

Filters applied: . Clear all
Page 1
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.
Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, Doria A, Fischer-Betz R, Forger F, Moraes-Fontes MF, Khamashta M, King J, Lojacono A, Marchiori F, Meroni PL, Mosca M, Motta M, Ostensen M, Pamfil C, Raio L, Schneider M, Svenungsson E, Tektonidou M, Yavuz S, Boumpas D, Tincani A. Andreoli L, et al. Ann Rheum Dis. 2017 Mar;76(3):476-485. doi: 10.1136/annrheumdis-2016-209770. Epub 2016 Jul 25. Ann Rheum Dis. 2017. PMID: 27457513 Free PMC article.
OBJECTIVES: Develop recommendations for women's health issues and family planning in systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS). ...Risk stratification includes disease activity, autoantibody profile, previous vascular and pregn …
OBJECTIVES: Develop recommendations for women's health issues and family planning in systemic lupus erythematosus (SLE) …
Systemic lupus erythematosus and menopause.
Gompel A. Gompel A. Climacteric. 2020 Apr;23(2):109-115. doi: 10.1080/13697137.2019.1679113. Epub 2019 Oct 28. Climacteric. 2020. PMID: 31657240 Review.
However, the severity of the disease may vary and some women with lupus could benefit from a menopausal hormone therapy (MHT). As a consequence, management of menopause symptoms needs to evaluate carefully the condition of the patient, her lupus histor …
However, the severity of the disease may vary and some women with lupus could benefit from a menopausal hormone therapy (MHT). …
Do Menopause and Aging Affect the Onset and Progression of Rheumatoid Arthritis and Systemic Lupus Erythematosus?
Shah L, Elshaikh AO, Lee R, Joy Mathew C, Jose MT, Cancarevic I. Shah L, et al. Cureus. 2020 Oct 14;12(10):e10944. doi: 10.7759/cureus.10944. Cureus. 2020. PMID: 33072443 Free PMC article. Review.
Rheumatoid arthritis and systemic lupus erythematosus (SLE) are autoimmune diseases that are commonly seen in the female population. ...However, aging and menopause caused the progression of SLE to decrease in women. An earlier age of onset of menop
Rheumatoid arthritis and systemic lupus erythematosus (SLE) are autoimmune diseases that are commonly seen in the femal …
Impact of menopause on women with systemic lupus erythematosus.
Karvonen-Gutierrez CA, Leis A. Karvonen-Gutierrez CA, et al. Maturitas. 2021 Dec;154:25-30. doi: 10.1016/j.maturitas.2021.09.004. Epub 2021 Sep 11. Maturitas. 2021. PMID: 34736577 Review.
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by chronic and systemic inflammation affecting multiple organ systems, including an increased risk of cardiovascular disease due to the SLE-associated hyperinflammatory state. ..
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by chronic and systemic inflammation a
Pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Practical messages from the EULAR guidelines.
Vagelli R, Tani C, Mosca M. Vagelli R, et al. Pol Arch Intern Med. 2017 Jan 25;127(2):115-121. doi: 10.20452/pamw.3906. Epub 2017 Jan 25. Pol Arch Intern Med. 2017. PMID: 28120818 Free article. Review.
Over the last few decades, reproductive medicine has observed an improvement in the management and outcome of pregnancy in connective tissue diseases, such as systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). ...In patients with stable/i …
Over the last few decades, reproductive medicine has observed an improvement in the management and outcome of pregnancy in connective tissue …
2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.
Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D'Anci KE. Sammaritano LR, et al. Arthritis Care Res (Hoboken). 2020 Apr;72(4):461-488. doi: 10.1002/acr.24130. Epub 2020 Feb 26. Arthritis Care Res (Hoboken). 2020. PMID: 32090466 Free article.
OBJECTIVE: To develop an evidence-based guideline on contraception, assisted reproductive technologies (ART), fertility preservation with gonadotoxic therapy, use of menopausal hormone replacement therapy (HRT), pregnancy assessment and management, and medication use in pa …
OBJECTIVE: To develop an evidence-based guideline on contraception, assisted reproductive technologies (ART), fertility preservation with go …
2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.
Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D'Anci KE. Sammaritano LR, et al. Arthritis Rheumatol. 2020 Apr;72(4):529-556. doi: 10.1002/art.41191. Epub 2020 Feb 23. Arthritis Rheumatol. 2020. PMID: 32090480 Free article.
OBJECTIVE: To develop an evidence-based guideline on contraception, assisted reproductive technologies (ART), fertility preservation with gonadotoxic therapy, use of menopausal hormone replacement therapy (HRT), pregnancy assessment and management, and medication use in pa …
OBJECTIVE: To develop an evidence-based guideline on contraception, assisted reproductive technologies (ART), fertility preservation with go …
Clinical implications of systemic lupus erythematosus without and with antiphospholipid syndrome in peri- and postmenopausal age.
Grygiel-Górniak B, Limphaibool N, Puszczewicz M. Grygiel-Górniak B, et al. Prz Menopauzalny. 2018 Jun;17(2):86-90. doi: 10.5114/pm.2018.77308. Epub 2018 Jun 30. Prz Menopauzalny. 2018. PMID: 30150916 Free PMC article. Review.
Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) displays a severe disease sub-phenotype with vascular manifestations ranging from peripheral thrombosis to neurologic and ophthalmic symptoms. ...In addition to the clinical h …
Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) displays a severe disease sub-pheno …
Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment.
Lazaro D. Lazaro D. Drugs Aging. 2007;24(9):701-15. doi: 10.2165/00002512-200724090-00001. Drugs Aging. 2007. PMID: 17727302 Review.
Systemic lupus erythematosus is an autoimmune multi-system disease of uncertain aetiology with highly variable clinical manifestations. ...This article discusses the prevalence, clinical course, serological features, prognosis and treatment of elderly-onset
Systemic lupus erythematosus is an autoimmune multi-system disease of uncertain aetiology with highly variable clinical
Pulmonary lymphangioleimyomatosis and systemic lupus erythematosus in a menopausal woman.
Hong H, Yang R, Li X, Wang M, Ma Z. Hong H, et al. BMC Nephrol. 2018 Apr 18;19(1):90. doi: 10.1186/s12882-018-0889-2. BMC Nephrol. 2018. PMID: 29669532 Free PMC article.
PLAM primarily affects young women, a characteristic it shares with systemic lupus erythematosus (SLE). Estrogen has long been assumed to play an important role both in PLAM and SLE. We report a menopausal woman, who was found to have PLAM 1 year after …
PLAM primarily affects young women, a characteristic it shares with systemic lupus erythematosus (SLE). Estrogen has lo …
306 results